# Finch Therapeutics Group Inc. (FNCH)

Source: https://www.quantisnow.com/company/FNCH
Generated: 2026-11-10T21:42:05.970Z

- Ticker: FNCH
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Biological Products (No Diagnostic Substances)
- IPO year: 2021
- Website: finchtherapeutics.com

## About

Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, develops a novel class of orally administered biological drugs in the United States. The company's lead candidate is CP101, an orally administered microbiome capsule that has completed Phase II clinical trial for the treatment of patients with recurrent Clostridioides difficile infection, as well as for the treatment of chronic hepatitis B virus. It is also developing FIN-211, an orally administered enriched consortia product candidate for use in the treatment of autism spectrum disorder; and FIN-524 and FIN-525, which are orally administered targeted consortia product candidates for the treatment of ulcerative colitis and crohn's disease. The company has collaboration and license agreements with Millennium Pharmaceuticals, Inc.; Skysong Innovations LLC; and University of Minnesota. Finch Therapeutics Group, Inc. was incorporated in 2014 and is based in Somerville, Massachusetts.

## Latest FNCH news and filings

- 2024-11-12 13:10 UTC [SEC Form 15-12G filed by Finch Therapeutics Group Inc.](https://www.quantisnow.com/insight/sec-form-15-12g-filed-by-finch-therapeutics-group-inc-5765530)
- 2024-11-05 05:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Finch Therapeutics Group Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-finch-therapeutics-group-inc-5751985)
- 2024-11-01 12:02 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Finch Therapeutics Group Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-finch-therapeutics-group-inc-5747608)
- 2024-11-01 12:02 UTC [SEC Form POS AM filed by Finch Therapeutics Group Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-finch-therapeutics-group-inc-5747607)
- 2024-11-01 12:02 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Finch Therapeutics Group Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-finch-therapeutics-group-inc-5747604)
- 2024-11-01 12:01 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Finch Therapeutics Group Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-finch-therapeutics-group-inc-5747599)
- 2024-10-31 12:00 UTC [SEC Form 25 filed by Finch Therapeutics Group Inc.](https://www.quantisnow.com/insight/sec-form-25-filed-by-finch-therapeutics-group-inc-5745528)
- 2024-10-21 11:45 UTC [SEC Form 8-K] [SEC Form 8-K filed by Finch Therapeutics Group Inc.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-finch-therapeutics-group-inc-5731130)
- 2024-10-21 11:30 UTC [Finch Announces Delisting from Nasdaq and SEC Deregistration](https://www.quantisnow.com/insight/finch-announces-delisting-from-nasdaq-and-sec-deregistration-5731090)
- 2024-08-13 20:16 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Finch Therapeutics Group Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-finch-therapeutics-group-inc-5656999)
- 2024-08-12 11:30 UTC [SEC Form 8-K] [SEC Form 8-K filed by Finch Therapeutics Group Inc.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-finch-therapeutics-group-inc-5653957)
- 2024-06-10 23:00 UTC [SEC Form 4] [Director Smisek Jeffery A gifted 767 shares, decreasing direct ownership by 2% to 17,870 units (SEC Form 4)](https://www.quantisnow.com/insight/director-smisek-jeffery-a-gifted-767-shares-decreasing-direct-ownership-5549400)
- 2024-05-25 00:00 UTC [SEC Form 4] [Smisek Jeffery A gifted 3,750 shares (SEC Form 4)](https://www.quantisnow.com/insight/smisek-jeffery-a-gifted-3750-shares-sec-form-4-5517868)
- 2024-05-24 10:05 UTC [SEC Form 8-K] [SEC Form 8-K filed by Finch Therapeutics Group Inc.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-finch-therapeutics-group-inc-5515189)
- 2024-05-17 20:45 UTC [SEC Form 8-K] [SEC Form 8-K filed by Finch Therapeutics Group Inc.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-finch-therapeutics-group-inc-5501183)
- 2024-05-10 20:45 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Finch Therapeutics Group Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-finch-therapeutics-group-inc-5482421)
- 2024-05-06 15:24 UTC [Market Chatter] [Finch Therapeutics Has Been Granted European Patent Number EP3664823 Titled "Composition For Use In Preventing Or Treating An Enterococcal Blood Stream Infection".](https://www.quantisnow.com/insight/finch-therapeutics-has-been-granted-european-patent-number-ep3664823-titled-5461650)
- 2024-04-26 20:57 UTC [SEC Form 10-K] [SEC Form 10-K/A filed by Finch Therapeutics Group Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-10-ka-filed-by-finch-therapeutics-group-inc-amendment-5438270)
- 2024-04-24 17:57 UTC [Market Insight] [Why Teledyne Technologies Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session](https://www.quantisnow.com/insight/why-teledyne-technologies-shares-are-trading-lower-by-9-here-5429320)
- 2024-04-17 17:36 UTC [Market Insight] [Why Travelers Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session](https://www.quantisnow.com/insight/why-travelers-shares-are-trading-lower-by-around-8-here-5415574)
- 2024-04-17 16:31 UTC [Market Insight] [12 Health Care Stocks Moving In Wednesday's Intraday Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-wednesdays-intraday-session-5415449)
- 2024-04-12 20:31 UTC [Market Insight] [12 Health Care Stocks Moving In Friday's After-Market Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-fridays-after-market-session-5408495)
- 2024-04-03 11:30 UTC [SEC Form 8-K] [SEC Form 8-K filed by Finch Therapeutics Group Inc.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-finch-therapeutics-group-inc-5387063)
- 2024-03-29 20:15 UTC [SEC Form 4] [Smisek Jeffery A sold $21,246 worth of shares (8,242 units at $2.58), closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/smisek-jeffery-a-sold-21246-worth-of-shares-8242-units-5377892)
- 2024-03-28 20:33 UTC [SEC Form 144] [SEC Form 144 filed by Finch Therapeutics Group Inc.](https://www.quantisnow.com/insight/sec-form-144-filed-by-finch-therapeutics-group-inc-5376127)
- 2024-03-25 21:48 UTC [Market Insight] [Finch Therapeutics Gr Q4 EPS $(1.89) Up From $(16.80) YoY](https://www.quantisnow.com/insight/finch-therapeutics-gr-q4-eps-189-up-from-1680-yoy-5367203)
- 2024-03-25 20:31 UTC [SEC Form 10-K] [SEC Form 10-K filed by Finch Therapeutics Group Inc.](https://www.quantisnow.com/insight/sec-form-10-k-filed-by-finch-therapeutics-group-inc-5366809)
- 2024-03-12 18:07 UTC [Market Insight] [Why Asana Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session](https://www.quantisnow.com/insight/why-asana-shares-are-trading-lower-by-11-here-are-5337348)
- 2024-03-12 13:05 UTC [Market Insight] [12 Health Care Stocks Moving In Tuesday's Pre-Market Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-tuesdays-pre-market-session-5336618)
- 2024-03-12 12:11 UTC [Market Insight] [Why Oracle Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket](https://www.quantisnow.com/insight/why-oracle-shares-are-trading-higher-by-around-13-here-5336314)
- 2024-02-23 21:12 UTC [SEC Form 8-K] [SEC Form 8-K filed by Finch Therapeutics Group Inc.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-finch-therapeutics-group-inc-5288359)
- 2023-12-13 22:20 UTC [SEC Schedule 13G] [SEC Form SC 13G filed by Finch Therapeutics Group Inc.](https://www.quantisnow.com/insight/sec-form-sc-13g-filed-by-finch-therapeutics-group-inc-5136257)
- 2023-11-27 21:54 UTC [SEC Form 4] [Smisek Jeffery A sold $5,351 worth of shares (1,470 units at $3.64), decreasing direct ownership by 18% to 6,642 units (SEC Form 4)](https://www.quantisnow.com/insight/smisek-jeffery-a-sold-5351-worth-of-shares-1470-units-5104706)
- 2023-11-22 21:37 UTC [SEC Form 144] [SEC Form 144 filed by Finch Therapeutics Group Inc.](https://www.quantisnow.com/insight/sec-form-144-filed-by-finch-therapeutics-group-inc-5101452)
- 2023-11-17 21:30 UTC [SEC Form 8-K] [Finch Therapeutics Group Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing](https://www.quantisnow.com/insight/finch-therapeutics-group-inc-filed-sec-form-8-k-notice-of-5093507)
- 2023-11-08 11:35 UTC [Market Chatter] [Finch Therapeutics Gr Q3 EPS $(1.51) Up From $(25.38) YoY](https://www.quantisnow.com/insight/finch-therapeutics-gr-q3-eps-151-up-from-2538-yoy-5068044)
- 2023-11-08 11:30 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Finch Therapeutics Group Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-finch-therapeutics-group-inc-5068030)
- 2023-09-29 18:09 UTC [Market Insight] [Stocks That Hit 52-Week Lows On Friday](https://www.quantisnow.com/insight/stocks-that-hit-52-week-lows-on-friday-4994785)
- 2023-09-19 16:50 UTC [Market Insight] [Stocks That Hit 52-Week Lows On Tuesday](https://www.quantisnow.com/insight/stocks-that-hit-52-week-lows-on-tuesday-4977942)
- 2023-08-14 17:48 UTC [Market Insight] [Stocks That Hit 52-Week Lows On Monday](https://www.quantisnow.com/insight/stocks-that-hit-52-week-lows-on-monday-4892116)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/FNCH
- Earnings history: https://www.quantisnow.com/earnings/FNCH
- Dividend history: https://www.quantisnow.com/dividends/FNCH
- Insider transactions: https://www.quantisnow.com/insiders/FNCH
- Options chain: https://www.quantisnow.com/options/FNCH
- SEC 8-K filings only: https://www.quantisnow.com/company/FNCH/8-k
- RSS and alerts for FNCH: https://www.quantisnow.com/docs/rss-feeds.md